These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24966600)

  • 21. [Long time oral supplementation with branched-chain amino acids improves survival and decreases recurrences in patients with hepatocellular carcinoma].
    Tsuchiya K; Asahina Y; Izumi N
    Nihon Shokakibyo Gakkai Zasshi; 2008 Jun; 105(6):808-16. PubMed ID: 18525186
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.
    Park JG; Tak WY; Park SY; Kweon YO; Jang SY; Lee YR; Bae SH; Jang JY; Kim DY; Lee JS; Suk KT; Kim IH; Lee HJ; Chung WJ; Jang BK; Suh JI; Heo J; Lee WK
    Medicine (Baltimore); 2017 Jun; 96(24):e6580. PubMed ID: 28614215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A snack enriched with oral branched-chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma.
    Takeshita S; Ichikawa T; Nakao K; Miyaaki H; Shibata H; Matsuzaki T; Muraoka T; Honda T; Otani M; Akiyama M; Miuma S; Ozawa E; Fujimito M; Eguchi K
    Nutr Res; 2009 Feb; 29(2):89-93. PubMed ID: 19285598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New support for branched-chain amino acid supplementation in advanced hepatic failure.
    Mascarenhas R; Mobarhan S
    Nutr Rev; 2004 Jan; 62(1):33-8. PubMed ID: 14995055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.
    Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK
    Nutrients; 2020 May; 12(5):. PubMed ID: 32429077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
    Takegoshi K; Honda M; Okada H; Takabatake R; Matsuzawa-Nagata N; Campbell JS; Nishikawa M; Shimakami T; Shirasaki T; Sakai Y; Yamashita T; Takamura T; Tanaka T; Kaneko S
    Oncotarget; 2017 Mar; 8(11):18191-18205. PubMed ID: 28212548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Branched-chain amino acids ameliorate fibrosis and suppress tumor growth in a rat model of hepatocellular carcinoma with liver cirrhosis.
    Cha JH; Bae SH; Kim HL; Park NR; Choi ES; Jung ES; Choi JY; Yoon SK
    PLoS One; 2013; 8(11):e77899. PubMed ID: 24223741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of branched chain amino acids supplementation in liver cirrhosis: A systematic review and meta-analysis.
    Konstantis G; Pourzitaki C; Chourdakis M; Kitsikidou E; Germanidis G
    Clin Nutr; 2022 Jun; 41(6):1171-1190. PubMed ID: 35500317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Branched-chain amino acid supplementation in treatment of liver cirrhosis: Updated views on how to attenuate their harmful effects on cataplerosis and ammonia formation.
    Holeček M
    Nutrition; 2017 Sep; 41():80-85. PubMed ID: 28760433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of oral administration of branched-chain amino acids supplementation on the mortality of patients with hepatocellular carcinoma: a meta-analysis].
    Xue WX; Yang F; Duan JJ; Sun JB; Peng H
    Zhonghua Yi Xue Za Zhi; 2020 Dec; 100(47):3793-3800. PubMed ID: 33379845
    [No Abstract]   [Full Text] [Related]  

  • 31. Branched-chain amino acid supplementation reduces oxidative stress and prolongs survival in rats with advanced liver cirrhosis.
    Iwasa M; Kobayashi Y; Mifuji-Moroka R; Hara N; Miyachi H; Sugimoto R; Tanaka H; Fujita N; Gabazza EC; Takei Y
    PLoS One; 2013; 8(7):e70309. PubMed ID: 23936183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Branched-chain amino acids as pharmacological nutrients in chronic liver disease.
    Kawaguchi T; Izumi N; Charlton MR; Sata M
    Hepatology; 2011 Sep; 54(3):1063-70. PubMed ID: 21563202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic oral branched-chain amino acid supplementation in a subpopulation of cirrhotics.
    Dioguardi FS; Brigatti M; Dell'Oca M; Ferrario E; Abbiati R
    Clin Physiol Biochem; 1990; 8(2):101-7. PubMed ID: 2361352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
    Moriwaki H; Miwa Y; Tajika M; Kato M; Fukushima H; Shiraki M
    Biochem Biophys Res Commun; 2004 Jan; 313(2):405-9. PubMed ID: 14684176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral supplementation with branched-chain amino acids improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis.
    Usui T; Moriwaki H; Hatakeyama H; Kasai T; Kato M; Seishima M; Okuno M; Ohnishi H; Yoshida T; Muto Y
    J Nutr; 1996 May; 126(5):1412-20. PubMed ID: 8618138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral supplementation of branched-chain amino acids reduces early recurrence after hepatic resection in patients with hepatocellular carcinoma: a prospective study.
    Ichikawa K; Okabayashi T; Maeda H; Namikawa T; Iiyama T; Sugimoto T; Kobayashi M; Mimura T; Hanazaki K
    Surg Today; 2013 Jul; 43(7):720-6. PubMed ID: 22890582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of a high-protein, high-fiber diet plus supplementation with branched-chain amino acids on the nutritional status of patients with cirrhosis.
    Ruiz-Margáin A; Macías-Rodríguez RU; Ríos-Torres SL; Román-Calleja BM; Méndez-Guerrero O; Rodríguez-Córdova P; Torre A
    Rev Gastroenterol Mex (Engl Ed); 2018; 83(1):9-15. PubMed ID: 28408059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis.
    Chen L; Chen Y; Wang X; Li H; Zhang H; Gong J; Shen S; Yin W; Hu H
    Nutr J; 2015 Jul; 14():67. PubMed ID: 26155840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nocturnal branched-chain amino acid administration improves protein metabolism in patients with liver cirrhosis: comparison with daytime administration.
    Fukushima H; Miwa Y; Ida E; Kuriyama S; Toda K; Shimomura Y; Sugiyama A; Sugihara J; Tomita E; Moriwaki H
    JPEN J Parenter Enteral Nutr; 2003; 27(5):315-22. PubMed ID: 12971730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Branched-chain amino acids protect the liver from cirrhotic injury via suppression of activation of lipopolysaccharide-binding protein, toll-like receptor 4, and signal transducer and activator of transcription 3, as well as Enterococcus faecalis translocation.
    Eguchi A; Iwasa M; Tamai Y; Tempaku M; Takamatsu S; Miyoshi E; Hasegawa H; Kobayashi Y; Takei Y
    Nutrition; 2021 Jun; 86():111194. PubMed ID: 33743328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.